What is the recommended dose of albumin (human albumin) for large volume paracentesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albumin Dosing for Large Volume Paracentesis

For large volume paracentesis (>5 liters), administer 6-8 grams of intravenous albumin per liter of ascitic fluid removed to prevent paracentesis-induced circulatory dysfunction and its associated complications. 1, 2

Volume-Based Dosing Algorithm

For paracentesis >5 liters:

  • Standard dose: 6-8 g albumin per liter of ascites removed 1, 2
  • Practical calculation examples:
    • 6 liters removed = 36-48 g albumin 2
    • 8 liters removed = 48-64 g albumin 2
    • 10 liters removed = 60-80 g albumin 2

For paracentesis <5 liters:

  • Albumin replacement is generally not required, as smaller volume removals are not associated with significant hemodynamic changes 1, 2
  • The risk of paracentesis-induced circulatory dysfunction is low in this setting 1

For paracentesis >8 liters:

  • Consider limiting fluid removal to <8 liters per session, as the risk of circulatory dysfunction increases significantly beyond this threshold 1, 2, 3
  • If >8 liters must be removed, albumin at 8 g/L is particularly important 2

Clinical Rationale and Evidence

Albumin is superior to all other plasma expanders for preventing paracentesis-induced circulatory dysfunction (PICD), which manifests as a >50% rise in plasma renin activity 4-6 days post-procedure 1, 3. The 2020 meta-analysis demonstrated that albumin reduces:

  • PICD by 61% (OR 0.39,95% CI 0.27-0.55) 1, 3
  • Mortality by 36% (OR 0.64,95% CI 0.41-0.98) 1, 3
  • Hyponatremia by 42% (OR 0.58,95% CI 0.39-0.87) 1, 3

Alternative plasma expanders (dextran-70, gelatin, hydroxyethyl starch, saline) are inferior and show higher rates of PICD compared to albumin 1, 3. Notably, hydroxyethyl starch can cause Kupffer cell dysfunction and worsen portal hypertension 1.

Formulation and Administration

Use 20-25% albumin solution (25 g per 100 mL for 25% solution) 2, 3

  • Both 20% and 25% solutions are isotonic 1
  • Avoid 5% albumin as it increases sodium load five-fold 1

Timing: Administer during or immediately after paracentesis completion 2, 3

Infusion rate: Give slowly to prevent cardiac overload, particularly in patients with preexisting cirrhotic cardiomyopathy 1, 3

Evidence on Reduced Dosing

While one pilot study in 70 patients with low-severity cirrhosis (MELD 16-17) suggested that 4 g/L may be non-inferior to 8 g/L 4, and a quality improvement study using 6.5 g/L showed no difference in outcomes compared to 8.3 g/L 5, the standard 6-8 g/L dose remains the guideline recommendation 1, 2. The studies comparing high-dose (6-8 g/L) versus low-dose (2-4 g/L) albumin showed no statistical difference in PICD rates, but uncertainty exists regarding the risk-benefit profile due to small sample sizes (N=120; RR 1.00,95% CI 0.22-4.49) 1.

Critical Distinctions

Do not confuse with spontaneous bacterial peritonitis (SBP) dosing, which uses a completely different weight-based regimen:

  • SBP: 1.5 g/kg within 6 hours of diagnosis, then 1.0 g/kg on day 3 1, 2, 3
  • Large volume paracentesis: 6-8 g per liter removed (volume-based, not weight-based) 1, 2, 3

Special Populations

High-risk patients (acute-on-chronic liver failure, high risk of acute kidney injury) should receive albumin at 8 g/L even for volumes <5 liters 2

Important Caveats

  • Monitor for circulatory overload, especially in patients with cardiac dysfunction 1, 3
  • Despite albumin administration, PICD may still occur in 14-20% of patients, though this is significantly lower than without albumin 4, 6
  • The 2024 Chest guidelines note that while albumin prevents PICD better than alternatives, evidence for mortality benefit remains uncertain in some analyses, though the most rigorous meta-analyses excluding inappropriate controls show mortality benefit 1
  • Serial paracenteses deplete proteins and may aggravate malnutrition 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Albumin Replacement Formula for Paracentesis in Ascites

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Administración de Albúmina en Paracentesis de Gran Volumen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2011

Research

Standardizing the Use of Albumin in Large Volume Paracentesis.

Journal of pharmacy practice, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.